Reproducibility of operator processing for radiation dosimetry

Nuclear Medicine and Biology

Volumn 24, Issue 1, 1997, Pages 77-83

  Shen, Sui ^a,c   DeNardo, Gerald L ^a   DeNardo, Sally J ^a   Yuan, Aina ^a   DeNardo, Diane A ^a   Lamborn, Kathleen R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Radiodiagnosis and Therapy   (United States)

Author keywords

dosimetry; radiation; radioimmunotherapy; reproducibility

Indexed keywords

COPPER 64; INDIUM 111; IODINE 131; MONOCLONAL ANTIBODY;

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; EDUCATION; FEMALE; HODGKIN DISEASE; HUMAN; MALE; OPERATOR; PHANTOM; RADIOIMMUNOTHERAPY; REPRODUCIBILITY;

EID: 0030934199     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00178-9     Document Type: Article

References (39)

1. Abi-Dargham A., Gandelman M., Zoglibi S. S., Laruelle M., Baldwin R. M., Randall P., Zea-Ponce Y., Charney D. S., Hoffer P. B. and Innis R. B. (1995) Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil. J. Nucl. Med. 36, 167-175.
2. Alazraki N. P., Krawczynska E. G., DePuey F. G., Ziffer J. A., Vansant J. P., Pettigrew R. I., Taylor A., King III S. B. and Garcia E. V. (1994) Reproducibility of thallium-201 exercise SPECT studies. J. Nucl. Med. 35, 1237-1244.
3. Brambilla M., Inglese E., Cannizaro G., Dondi M., Sara R., Arrigo F. and Tarolo G. L. (1994) A multicenter trial on interobserver and intraobserver reproducibility of segmental scoring of thallium-201 planar myocardial imaging before and after rejection. J. Nucl. Med. 35, 601-608.
4. DeNardo G. L., DeNardo S. J., Macey D. J. and Mills S. L. (1988) Quantitative pharmacokinetics of radiolabeled monoclonal antibodies for imaging and therapy in patients. In: Radiolabeled Monoclonal Antibodies for Imaging and Therapy (Edited by Srivastava S. C.). pp 293-310, Plenum Publishing, New York.
5. 131I-Lym-1 monoclonal antibodies. Int. J. Cancer 3, 96-101.
6. DeNardo G. L., DeNardo S. J., Meares C. F., Kukis D. L., Diril H., McCall M. J., Adams G. P., Mausner L. F. and Moody D. C., Deshpande S.V. (1991) Pharmacokinetics of copper-67 conjugated Lym-1, a potential therapeutic radioimmuno-conjugate, in mice and in patients with lymphoma. Antibody Immunoconj. Radiophar. 4, 777-785.
7. DeNardo S. J., O'Grady L. F., Macey D. J., Kroger L. A., DeNardo G. L., Lamborn K. R., Levy N. B., Mills S. L., Hellstrom I. and Hellstrom K. E. (1991) Quantitative imaing of mouse L-6 monoclonal antibody in breast cancer patietns to develop a therapeutic strategy. Nucl. Med. Biol. 18, 621-631
8. DeNardo S. J., Mirick G. R., Kroger L. A., O'Grady L. F., Erickson K. L., Yuan A., Lamborn K. R., Hellstrom I., Hellstrom K. E. and DeNardo G. L. (1994) The biological window for chimeric L6 radioimmunotherapy. Cancer (Suppl). 73, 1023-1032.
9. DeNardo G. L. , DeNardo S. J. (1995) Overview of obstacles and opportunities for radioimmunotherapy of cancer. In Cancer Therapy with Radiolabeled Antibodies (Edited by Goldenberg D. M.), pp. 141-153, CRC Press, Boca Raton.
10. DeNardo S. J. (1995) Radioimmunotherapy in treatment of metastatic breast cancer: An overview. In: Cancer Therapy with Radiolabeled Antibodies (Edited by Goldenberg D. M.), pp. 189-201, CRC Press, Boca Raton.
11. DeNardo G. L., Lamborn K. R., DeNardo S. J., Goldstein D. S., Dolber-Smith E. G., Kroger L. A., Larkin E. C. and Shen S. (1995) Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignancies. Cancer Res. (Suppl). 55, 5916s-5920s.
12. 90Y-DOTA-peptide in tumor bearing mice. J. Nucl. Med. 36, 829-836.
13. Eary J. F., Appelbaum F. L., Durack L., Brown P. (1989) Preliminary validation of the opposing view method for quantitative gamma camera imaging. Med. Phys. 16, 382-387.
14. Erwin W. D., Groch M. W, Macey D. J., DeNardo G. L., DeNardo S. J. and Shen S. (1996) A radioimmunoimaging and MIRD dosimetry treatment planning program for radioimmunotherapy. Nucl .Med. Biol. 23, 525-532.
15. Gilland D. R., Jaszczak R. J., Turkington T. G., Greet K. L. and Coleman R. E. (1994) Volume and activity quantitation with iodine-123 SPECT. J. Nucl. Med. 35, 1707-1713.
16. Goldenberg D. M. (1995) Carcinoembryonic antigen as a target cancer antigen for radiolabeled antibodies: Prospects for cancer imaging and therapy. Tumor Biol. 16, 62-73.
17. 2 fragments of monoclonal antibody in humans. Med. Phys. 11, 778-783.
18. Koral K. F., Zasadny K. R., Kessler M. L., Lou J. Q., Buchbinder S. F., Kaminiski M. S., Francis I. and Wahl R. L. (1994) CT-SPECT fusion plus conjugate views for determining dosimetry in iodine-131-monoclonal antibody therapy of lymphoma patients. J. Nucl. Med. 35, 1714-1720.
19. Koran L. M. (1975) The reliability of clinical methods, data and judgments. N. Engl. J. Med. 293, 642-695.
20. Larson S. M., Macapinlac H. A., Scott A. M. and Divgi C. R. (1993) Recent achievements in the development of radiolabeled monoclonal antibodies for diagnosis, therapy, and biological characterization of human tumors. Acta Oncologica 32, 709-715.
21. Loevinger R. and Bermam M. (1976) A revised schema for calculating the absorbed dose from biologically distributed radionuclides. MIRD Pamphlet No. 1, Society of Nuclear Medicine. New York.
22. Macey D. J., DeNardo G. L. and DeNardo S. J. (1990) A treatment planning program for radioimmunotherapy. In: Frontiers of Radiation Therapy and Oncology (Edited by Vaeth J. M. and Meyer J. L.), pp. 123-131, Basel, Karger, Swaziland.
23. Order S. E., Siegel J. A., Lustig R. A., Principato R., Zeiger L. S., Johnson E., Zhang H., Lang P., Pilchik N. B., Metz J. et al. (1994) A new method for delivering radiation cytotoxic agents in solid cancer. Int. J. Radiat. Oncol. Biol. Phys. 30, 715-720.
24. Press O. W., Eary J. F., Appelbaum F. R., Martin P. J., Badger C. C., Nelp W. B., Glenn S., Butchko G., Fisher D., Porter B., Matthews D. C., Fisher L. D. and Bernstein I. D. (1993) Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N. Engl. J. Med. 329, 1219-1224.
25. Pretoris H. P., Aswegen A. V., Lotter M. G., Herbst C. P., Nel M. G. and Otto A. C. (1993) Verification of a varying threshold edge detection SPECT technique for spleen volume: A comparison with computed tomography volumes. J. Nucl. Med. 34, 963-967.
26. 111In planar image quantification. Med. Phys. 15, 853-861.
27. Shen S., DeNardo G. L., Yuan A., DeNardo D. A. and DeNardo S. J. (1994) Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung. J. Nucl. Med. 35, 1379-1387.
28. Shen S., DeNardo G. L. and DeNardo S. J. (1994) Quantitative bremsstrahlung imaging of yttrium-90 using a Wiener filter. Med. Phys. 21, 1409-1417.
29. 67Cu-2IT-BAT-Lym-1 for radioimmunotherapy. J. Nucl. Med. 37, 146-150.
30. Shulkin B. L., Sisson J. C., Koral K. F., Shapiro B., Wang X. and Johnson J. (1988) Conjugate view gamma camera method for estimating tumor uptake of iodine-131 Metaiodobenzylguanidme, J. Nucl. Med. 29, 542-548.
31. Snedecor G. W. and Cochran W. G. (1980) Statistical methods. pp238-254, The Iowa state university press, Ames, Iowa.
32. Snyder W. S., Ford M. R., Warner G. G. and Waston S. B. (1975) "S," Absorbed dose per unit cumulated activity for selected radionuclides and organs. MIRD Pamphlet No. 11, Society of Nuclear Medicine, New York.
33. Sorenson J. A. (1976) Methods of correcting Anger camera deadtime losses. J. Nucl. Med. 17, 137-141
34. 131I labeled monoclonal antibodies. Int. J. Radiat. Oncol. Biol. Phys. 16, 405-413.
35. Thomas S. R., Maxon H. R. and Kereiakes J. G. (1976) In vivo quantitation of lesion radioactivity using external counting methods. Med. Phys. 3, 253-255.
36. 2 antibody injected into the same patients. J. Nucl. Med. 32, 221-226.
37. Weber D. A., Eckerman K. F., Dillman L. T. and Ryman J. C. (1989) MIRD: Radionuclide data and decay schemes. Society of Nuclear Medicine, New York.
38. Wiener B. J. (1971) Statistical principles in experimental design, pp. 261-297, Mc-Graw Hill, New York.
39. Yang L. D., Bairey C. N., Berman D. S., Nichols K. J., Odom-Maryon T. and Rozanski A. (1991) Accuracy and reproducibility of left ventricular ejection fraction measurements using an radionuclide left ventricular function monitor. J. Nucl. Med. 32, 796-802.